Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
European Annals of Allergy and Clinical Immunology is Scopus-indexed (Q2, CiteScore 5.1), WoS ESCI. Published by EDRA SpA.
Checked against the index lists dated .
ISSN 1764-1489Verify ISSN ↗
Publisher: EDRA SpA
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 108 / 234 | 54th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2003–present, best quartile Q2, CiteScore 5.1.
European Annals of Allergy and Clinical Immunology is Q2 in Immunology and Allergy (rank 108 of 234), by CiteScore 2025.
European Annals of Allergy and Clinical Immunology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.696, quartile Q3, with an H-index of 40.
European Annals of Allergy and Clinical Immunology is published by EDRA SpA. Its ISSN is 1764-1489.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
European Annals of Allergy and Clinical Immunology has an h-index of 24 and a 2-year mean of 1.25 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q2. On 2-year citations it ranks #157 of 231 Scopus journals in Immunology and Allergy.
European Annals of Allergy and Clinical Immunology published 41 papers in 2025; its busiest recent year was 2020 with 58. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2024–2026), authors are most often from Italy (42.6%), Portugal (20.5%) and Spain (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.